The US Food and Drug Administration on Friday approved a new type of drug to treat hot flashes and night sweats during menopause.Veozah, or fezolinetant, made by Astellas Pharma, is the first neurokinin 3 (NK3) agonist.It blocks receptors in the brain that play a role in the regulation of body temperature.
[
add
]
[
|
|
...
]